Draxis Health Inc.
http://www.draxis.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Draxis Health Inc.
Molecular Targeting Technology Inc.
Molecular Targeting Technology is developing radiopharmaceuticals for nuclear medicine and targeting agents for drug delivery. The company's lead product, {Amiscan} uses a small-molecule radiotracer to diagnose heart attack.
Company Information
- Industry
- Contract Research, Toxicology Testing-CRO
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
- Specialty Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice